Top Markets
Coin of the day
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
株式のランク #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
株価
$48.45
時価総額
$1.39B
変化(1日)
1.16%
変化(1年)
-
US
取引 LB Pharmaceuticals Inc Common Stock (LBRX)

カテゴリー

LB Pharmaceuticals Inc Common Stock(LBRX)の配当利回りの履歴
LB Pharmaceuticals Inc Common Stock(銘柄コード: LBRX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
LB Pharmaceuticals Inc Common Stock(LBRX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)